Kapil B. Chopra

Kapil Chopra practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Kapil Chopra's NPI, 1346225844, was assigned on December 7, 2005. Kapil Chopra holds Pennsylvania license MD069646L.

Kapil Chopra's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Kapil Chopra's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Kapil Chopra is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Kapil Chopra to 5 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kapil Chopra practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Kapil Chopra's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Kapil Chopra is licensed in Pennsylvania.

CMS data shows 132 Medicare services from Kapil Chopra across 6 procedure codes in 2024, for 155 Medicare patients. Medicare paid $9,411 for them.

CMS counts 155 Medicare patients who saw Kapil Chopra in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kapil Chopra's median patient age at 69, with 49% women.

In 2024, Kapil Chopra wrote 770 Medicare Part D claims for 150 patients. 82% of them were for generic drugs. CMS names the drug for 700 of them, across 15 drugs with 11 or more claims each, at $349,365 in total drug cost. In 2023, CMS named 825 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Kapil Chopra for performance year 2024, reported as part of a group. Kapil Chopra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Kapil Chopra, more than 55% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Kapil Chopra, published from 2012 to 2023. 2014 was the busiest year, with 3. The most frequent topics are Carcinoma, Hepatocellular, Liver Cirrhosis and Liver Neoplasms. Kapil Chopra's most frequent co-authors are Jaideep Behari, MD, Arun Bansal, MD and Naga Prasad Chalasani, MD.

Dmand AI links Kapil Chopra to 1 clinical trial. Conditions studied include alpha 1-Antitrypsin Deficiency and Subcutaneous Emphysema.

CMS Open Payments shows 1 general payment to Kapil Chopra from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $78.